BrightGene Bio-Medical Technology Co. Ltd.SSE: 688166

Announcement on Outward Investment and Related Party Transactions

· Issued by BrightGene Bio-Medical Technology Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · · 11 pages · Chinese

Summary by 6ix AI

BrightGene Bio-Medical Technology Co. Ltd. announced an outward investment and related party transactions involving an increase in capital for a subsidiary. This transaction is classified as a related party transaction due to the involvement of a board member in the investment decision. The investment is aimed at supporting the development of innovative antibody drugs, although the target company currently faces financial challenges.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Announcement on Outward Investment and Related Party Transactions

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

BrightGene Bio-Medical Technology Co. Ltd. on 6ix

Earlier from BrightGene Bio-Medical Technology

Later from BrightGene Bio-Medical Technology

All BrightGene Bio-Medical Technology news releases